Yes, Toradol (ketorolac) is an NSAID, or nonsteroidal anti-inflammatory drug. It belongs to the same broad drug class as ibuprofen and naproxen, but it is significantly more potent and is typically reserved for moderate to severe pain in hospital or clinical settings. Unlike most NSAIDs you can pick up at a pharmacy, Toradol is a prescription medication with a strict five-day limit on use.
How Toradol Works
Like all NSAIDs, Toradol reduces pain and inflammation by blocking enzymes called COX-1 and COX-2. It is a non-selective inhibitor, meaning it blocks both. COX-2 is the enzyme your body ramps up at sites of injury or inflammation, and blocking it is what provides pain relief. COX-1, on the other hand, handles everyday maintenance tasks: protecting your stomach lining, supporting kidney blood flow, and helping your blood clot normally. Blocking COX-1 is the reason Toradol (and other NSAIDs) can cause stomach irritation, kidney strain, and increased bleeding.
What sets Toradol apart from over-the-counter NSAIDs is its analgesic potency. In a double-blind study comparing intramuscular ketorolac to morphine after major surgery, ketorolac at 10 mg and 30 mg matched the pain relief of 12 mg of morphine over a full six-hour observation period. At 90 mg, ketorolac actually outperformed morphine 12 mg. That makes it one of the strongest non-opioid pain relievers available, which is a major reason clinicians reach for it when they want to manage severe pain without narcotics.
How Toradol Differs From Ibuprofen
Toradol and ibuprofen share the same mechanism, but they are not interchangeable. Toradol is given by injection (into a vein or muscle) or as a nasal spray in most clinical situations. An oral tablet exists, but the FDA requires that it only be used as a follow-up after someone has already received the injectable form. You cannot start treatment with the pill alone.
In terms of raw pain control, the two drugs perform similarly when given intravenously at standard doses. A randomized clinical trial comparing IV ketorolac to IV ibuprofen after urogynecologic surgery found no significant difference in overall pain scores at rest or while walking. However, in a subgroup of patients who had open abdominal surgery (laparotomy), those receiving ketorolac reported meaningfully lower pain at rest and higher satisfaction scores. So while the drugs overlap in many scenarios, ketorolac may have an edge for more invasive procedures.
The practical difference for most people is access. Ibuprofen and naproxen are available over the counter for everyday aches and mild to moderate pain. Toradol requires a prescription and is most commonly given in emergency rooms, surgical recovery areas, and urgent care clinics for pain that is too severe for OTC options but where opioids are not ideal.
The Five-Day Rule
Toradol carries one of the most notable usage restrictions of any NSAID: treatment must not continue beyond five days total, combining all routes of administration. This limit exists because the risks of serious side effects rise sharply with extended use. Those risks include heart-related blood clots, kidney failure, peptic ulcers, and dangerous bleeding. The five-day cap applies whether you receive the drug by injection, nasal spray, or oral tablet.
This is a hard cutoff, not a guideline. Most people encounter Toradol as a single dose in an ER or as a short course after surgery, so the limit rarely becomes an issue in practice.
Who Should Not Take Toradol
Because Toradol is a powerful NSAID, its list of contraindications is longer and more strictly enforced than what you see with ibuprofen. You should not receive Toradol if you have:
- Active stomach ulcers or recent GI bleeding. The drug reduces the protective lining of the stomach and intestines, making existing ulcers worse or causing perforation.
- A history of asthma or allergic reactions triggered by aspirin or other NSAIDs. Cross-reactivity is common in this drug class.
- Advanced kidney problems or dehydration. Toradol reduces blood flow to the kidneys, which can push compromised kidneys into failure.
- Bleeding disorders or suspected brain bleeding. Toradol inhibits platelet function, impairing your blood’s ability to clot.
- An upcoming or recent major surgery, particularly coronary artery bypass grafting (CABG). The FDA specifically prohibits its use as a preventive painkiller before major surgery and during CABG recovery.
Toradol also cannot be used during labor and delivery because it interferes with uterine contractions and can affect fetal circulation. And it should not be combined with aspirin, other NSAIDs, or certain medications like probenecid and pentoxifylline due to compounding risks.
What to Expect if You Receive It
If you are given Toradol in a clinical setting, it is typically a single injection into a muscle or vein. Pain relief generally begins within 30 minutes of an intramuscular dose and can last up to six hours. For adults under 65, a standard single IV dose is 30 mg; for those 65 and older, or weighing under 110 pounds, or with kidney concerns, the dose drops to 15 mg.
If your pain requires ongoing management for a few days after leaving the clinic, you may be sent home with a short course of oral ketorolac tablets, typically 10 mg every four to six hours with a ceiling of 40 mg per day. This always counts toward the five-day total. Side effects during short-term use are generally the same as other NSAIDs: stomach discomfort, headache, dizziness, and mild swelling. The more serious risks (GI bleeding, kidney problems, cardiovascular events) are the reason the drug is kept to such a short window.
Toradol occupies a unique niche: it is an NSAID strong enough to rival opioids for acute pain, without the sedation, respiratory depression, or addiction risk that opioids carry. That combination of power and safety trade-offs is why it is both widely used in hospitals and tightly restricted in duration.